Fig. 2From: New opportunities for RGD-engineered metal nanoparticles in cancerFluorescence images of in vitro staining of human glioblastoma U87MG (high integrin αvβ3 expression) and human breast cancer MCF-7 (integrin αvβ3 negative) using RGD-modified UCP nanoparticles. Reproduced with permission from ref [77]Back to article page